Research Topic · Peer-Reviewed

Nonsurgical Tumor Ablation

Nonsurgical tumor ablation is a type of minimally invasive cancer treatment where targeted tissue is destroyed using various energy sources such as heat, cold, radiofrequency, and lasers. The technique involves inserting a needle or probe into the tumor site and directing energy towards the cancer cells. This techno…

📚 0 peer-reviewed articles cited 🔖 ISSN 2372-6601 🗓 Reviewed June 2026

Overview

Nonsurgical tumor ablation is a type of minimally invasive cancer treatment where targeted tissue is destroyed using various energy sources such as heat, cold, radiofrequency, and lasers. The technique involves inserting a needle or probe into the tumor site and directing energy towards the cancer cells. This technology is widely used in oncology, as it provides a safe, effective, and convenient alternative to traditional cancer treatments like surgery or chemotherapy. The benefits of nonsurgical tumor ablation are numerous. First and foremost, it is a minimally invasive procedure that can be done in an outpatient setting. This means that patients can avoid the risks and complications associated with surgery, such as infection, bleeding, and scarring. Additionally, nonsurgical tumor ablation is less painful, and recovery time is shorter, allowing patients to resume their normal activities within a few days. Nonsurgical tumor ablation is highly effective in treating various cancers, including liver, prostate, breast, and lung cancers. It is also useful in treating metastatic cancer, where tumors have spread to other parts of the body. The technique can be repeated multiple times, which makes it a viable option for patients who are not suitable for surgery or those who have experienced cancer recurrence. In conclusion, nonsurgical tumor ablation is a cutting-edge technology that offers great promise in the field of oncology. It is a safe and effective treatment option for patients with cancer, providing superior outcomes with fewer risks and complications than traditional cancer treatments. As research in this area continues, it is expected that nonsurgical tumor ablation will continue to become an integral part of cancer care, contributing to improved patient survival rates and quality of life.

Research published in this journal

No peer-reviewed research on this exact topic has been published in Hematology and Oncology Research yet. Browse the journal →

Editorial oversight

Curated from peer-reviewed research published in Hematology and Oncology Research (ISSN 2372-6601).

Journal editorial board
Jayadev Manikkam Umakanthan · United States Shuaiying Cui · United States Benedetto Sacchetti · Italy

This page summarises published research for orientation; it is not medical or professional advice.